Citation Impact
Citing Papers
Mechanisms underlying the resistance to diet-induced obesity in germ-free mice
2007 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Primary Prevention of Ischemic Stroke
2006
Ligand-tethered lipid nanoparticles for targeted RNA delivery to treat liver fibrosis
2023 StandoutNobel
Lipoprotein lipase
2002
Associations of cardiovascular biomarkers and plasma albumin with exceptional survival to the highest ages
2020
Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge
2017 StandoutNobel
An integrated map of genetic variation from 1,092 human genomes
2012 StandoutNature
Lipid-like materials for low-dose, in vivo gene silencing
2010
An Expanded View of Complex Traits: From Polygenic to Omnigenic
2017 Standout
Prognostic Value of B-Type Natriuretic Peptides in Patients With Stable Coronary Artery Disease
2007
Association of Loss-of-Function Mutations in the <emph type="ital">ABCA1</emph> Gene With High-Density Lipoprotein Cholesterol Levels and Risk of Ischemic Heart Disease
2008
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
Biochemistry and pathophysiology of intravascular and intracellular lipolysis
2013
Multiple Biomarkers for the Prediction of First Major Cardiovascular Events and Death
2006 Standout
Novel mechanism for regulation of extracellular SOD transcription and activity by copper: Role of antioxidant-1
2008
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
2016 Standout
Effects of Torcetrapib in Patients at High Risk for Coronary Events
2007 Standout
Gene transfer of extracellular superoxide dismutase improves endothelial function in rats with heart failure
2005
Meta-analysis of Genetic Studies in Ischemic Stroke
2004
Nonfasting Triglycerides and Risk of Myocardial Infarction, Ischemic Heart Disease, and Death in Men and Women
2007 Standout
Effect of Torcetrapib on the Progression of Coronary Atherosclerosis
2007
Extracellular superoxide dismutase (ecSOD) in vascular biology: an update on exogenous gene transfer and endogenous regulators of ecSOD
2007
The metabolic syndrome
2010 Standout
Extracellular SOD-Derived H2O2 Promotes VEGF Signaling in Caveolae/Lipid Rafts and Post-Ischemic Angiogenesis in Mice
2010
Hallmarks of aging: An expanding universe
2023 Standout
Inhibition of CETP activity by torcetrapib reduces susceptibility to diet-induced atherosclerosis in New Zealand White rabbits
2007
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical Utilization of Cardiac Biomarker Testing in Heart Failure
2007
The mini-driver model of polygenic cancer evolution
2015 StandoutNobel
The changing landscape of atherosclerosis
2021 StandoutNature
Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome
2005 Standout
Lipoprotein lipase: the regulation of tissue specific expression and its role in lipid and energy metabolism
2002
Guidelines for the Primary Prevention of Stroke
2010
An ionizable lipid toolbox for RNA delivery
2021 StandoutNobel
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
Admission B-Type Natriuretic Peptide Levels and In-Hospital Mortality in Acute Decompensated Heart Failure
2007
Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studies
2003
Mendelian randomization: genetic anchors for causal inference in epidemiological studies
2014 Standout
Triglycerides and cardiovascular disease
2014
Clan Genomics and the Complex Architecture of Human Disease
2011
The metabolic syndrome
2005 Standout
Genetically Elevated C-Reactive Protein and Ischemic Vascular Disease
2008
Natriuretic Peptides
2007
Type 1 diabetes
2013 Standout
The Structure of Human Extracellular Copper–Zinc Superoxide Dismutase at 1.7 Å Resolution: Insights into Heparin and Collagen Binding
2009
C-reactive protein and its role in metabolic syndrome: mendelian randomisation study
2005
Factor V Leiden and prothrombin G20210A mutations in young adults with cryptogenic ischemic stroke
2004
Genetics and pathogenesis of inflammatory bowel disease
2011 StandoutNature
Penetrance of NOD2/CARD15 genetic variants in the general population
2010
What We Talk About When We Talk About Fat
2014 Standout
Low-Density Lipoprotein Size and Cardiovascular Disease: A Reappraisal
2003
Statistical analysis strategies for association studies involving rare variants
2010
Atherosclerosis
2000 StandoutNature
Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis
2011 Standout
Metastatic colonization by circulating tumour cells
2016 StandoutNature
Pros and cons of inhibiting cholesteryl ester transfer protein
2000
Angiotensin-converting enzyme and p22phox polymorphisms and the risk of coronary heart disease in a low-risk Spanish population
2004
Integrins
2002 Standout
Biomarkers in Heart Failure
2008 Standout
Superoxide Dismutases: Role in Redox Signaling, Vascular Function, and Diseases
2011 Standout
Gene therapy for dyslipidemia: a review of gene replacement and gene inhibition strategies
2010
Phenotypic Heterogeneity of the Endothelium
2007
Primary Prevention of Ischemic Stroke
2001
Stroke Prevention Therapy Beyond Antithrombotics: Unifying Mechanisms in Ischemic Stroke Pathogenesis and Implications for Therapy
2002
C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis
2009 Standout
Lipoprotein Lipase Mutations, Plasma Lipids and Lipoproteins, and Risk of Ischemic Heart Disease
1999
Guidelines for the Primary Prevention of Stroke
2014 Standout
Adaptive and Maladaptive Cardiorespiratory Responses to Continuous and Intermittent Hypoxia Mediated by Hypoxia-Inducible Factors 1 and 2
2012 StandoutNobel
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack
2006 Standout
Endocytosis of Extracellular Superoxide Dismutase Into Endothelial Cells
2006
Advances in the Chemistry of Tetrahydroquinolines
2011 Standout
Oral Cholesteryl Ester Transfer Protein (CETP) Inhibitors: A Potential New Approach for Treating Coronary Artery Disease
2005
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Testing for Inherited Thrombophilias in Arterial Stroke
2010
Lipoprotein-Associated Phospholipase A2 Predicts 5-Year Cardiac Mortality Independently of Established Risk Factors and Adds Prognostic Information in Patients with Low and Medium High-Sensitivity C-Reactive Protein (The Ludwigshafen Risk and Cardiovascular Health Study)
2007
Type 1 Diabetes and Coronary Artery Disease
2006
Primary Prevention of Ischemic Stroke
2001
Pathophysiology of Sleep Apnea
2010 Standout
Renal Considerations in Angiotensin Converting Enzyme Inhibitor Therapy
2001
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
The gut microbiota as an environmental factor that regulates fat storage
2004 Standout
Insertion-Deletion Polymorphism of the ACE Gene Modulates Reversibility of Endothelial Dysfunction With ACE Inhibition
2000
Particulate Matter Air Pollution and Cardiovascular Disease
2010 Standout
Cholesteryl Ester Transfer Protein
2003
The Metabolic Syndrome
2008 Standout
Vascular Effects of the Human Extracellular Superoxide Dismutase R213G Variant
2005
Oxidant stress—a major cause of reduced endothelial nitric oxide availability in cardiovascular disease
2005
Fourth universal definition of myocardial infarction (2018)
2018 Standout
Scalable mRNA and siRNA Lipid Nanoparticle Production Using a Parallelized Microfluidic Device
2021 StandoutNobel
Inactivation of Extracellular Superoxide Dismutase Contributes to the Development of High-Volume Hypertension
2006
Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment
2022 StandoutNobel
Throughput-scalable manufacturing of SARS-CoV-2 mRNA lipid nanoparticle vaccines
2023 StandoutNobel
Phospholipase A2Enzymes: Physical Structure, Biological Function, Disease Implication, Chemical Inhibition, and Therapeutic Intervention
2011 Standout
Essential role for the Menkes ATPase in activation of extracellular superoxide dismutase: implication for vascular oxidative stress
2005
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack
2010 Standout
High-Dose Atorvastatin after Stroke or Transient Ischemic Attack
2006 Standout
Platelet Glycoprotein IIb-IIIa Antagonists as Prototypical Integrin Blockers: Novel Parenteral and Potential Oral Antithrombotic Agents
2000
Treatment of erythropoietin deficiency in mice with systemically administered siRNA
2012 StandoutNobel
Works of Rolf Steffensen being referenced
Hepatic lipase mutations,elevated high-density lipoprotein cholesterol, and increased risk of ischemic heart disease
2003
A common substitution (Asn291Ser) in lipoprotein lipase is associated with increased risk of ischemic heart disease.
1997
N-Terminal Pro–B-Type Natriuretic Peptide and Long-Term Mortality in Stable Coronary Heart Disease
2005
Apolipoprotein E genotype: epsilon32 women are protected while epsilon43 and epsilon44 men are susceptible to ischemic heart disease
2000
Metabolic syndrome and mortality in stable coronary heart disease: Relation to gender
2007
Prevalence and significance of troponin elevations in patients without acute coronary disease
2016
The Angiotensin-converting Enzyme Inhibition Post Revascularization Study (APRES)
2000
Subsets of SNPs define rare genotype classes that predict ischemic heart disease
2006
Mutations in thelipoprotein lipaseGene Associated With Ischemic Heart Disease in Men
1999
Elevated HDL Cholesterol Is a Risk Factor for Ischemic Heart Disease in White Women When Caused by a Common Mutation in the Cholesteryl Ester Transfer Protein Gene
2000
Common Cholesteryl Ester Transfer Protein Mutations, Decreased HDL Cholesterol, and Possible Decreased Risk of Ischemic Heart Disease
2000
Factor V Leiden: The Copenhagen City Heart Study and 2 meta-analyses
2002
Angiotensinogen Mutations and Risk for Ischemic Heart Disease, Myocardial Infarction, and Ischemic Cerebrovascular Disease: Six Case–Control Studies from the Copenhagen City Heart Study
2001
Angiotensinogen mutations and risk of ischemic heart disease, myocardial infarction and ischemic cerebrovascular disease. Six case-control studies based on the Copenhagen City heart study
2001
ACE Gene Polymorphism: Ischemic Heart Disease and Longevity in 10 150 Individuals
1997
Genetically Reduced Antioxidative Protection and Increased Ischemic Heart Disease Risk
2003
Heterozygous Lipoprotein Lipase Deficiency
1997
Association of Mutations in the Apolipoprotein B Gene with Hypercholesterolemia and the Risk of Ischemic Heart Disease
1998
Phenotype of Heterozygotes for Low-Density Lipoprotein Receptor Mutations Identified in Different Background Populations
2004